|
Volumn 26, Issue 1, 2003, Pages 73-78
|
Inhibitory effect of acyl-CoA: Cholesterol acyltransferase inhibitor-low density lipoprotein complex on experimental atherosclerosis
|
Author keywords
Acyl CoA: cholesterol acyltransferase (ACAT) inhibitor; Drug delivery: antiatherosclerosis; Drug low density lipoprotein (LDL) complex
|
Indexed keywords
CHOLESTEROL ACYLTRANSFERASE INHIBITOR;
DRUG CARRIER;
INFUSORIAL EARTH;
KV 2920;
LOW DENSITY LIPOPROTEIN;
N (1 DECYL 4,6 DIMETHYLINDOLIN 7 YL) 2,2 DIMETHYLPROPANAMIDE;
UNCLASSIFIED DRUG;
CHOLESTEROL ACYLTRANSFERASE;
ENZYME INHIBITOR;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
AORTA;
ARTICLE;
ATHEROSCLEROSIS;
BIOACCUMULATION;
CELL LEVEL;
CHOLESTEROL BLOOD LEVEL;
COMPLEX FORMATION;
CONTROLLED STUDY;
DRUG EFFICACY;
FOAM CELL;
HEART PROTECTION;
INCUBATION TIME;
MACROPHAGE;
MALE;
MOUSE;
NONHUMAN;
ANIMAL;
ARTERIOSCLEROSIS;
COMPARATIVE STUDY;
DRUG ANTAGONISM;
ENZYMOLOGY;
INSTITUTE FOR CANCER RESEARCH MOUSE;
METABOLISM;
ANIMALS;
ARTERIOSCLEROSIS;
ENZYME INHIBITORS;
LIPOPROTEINS, LDL;
MALE;
MICE;
MICE, INBRED ICR;
STEROL O-ACYLTRANSFERASE;
|
EID: 0037706822
PISSN: 09186158
EISSN: None
Source Type: Journal
DOI: 10.1248/bpb.26.73 Document Type: Article |
Times cited : (5)
|
References (21)
|